Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, 2 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 3 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
14 Sep 2019
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.

Cystic features, contrast enhancement predict risk of nondiagnostic findings in renal mass biopsy

31 May 2019

A recent study has shown that procedural complications following percutaneous core renal mass biopsy are uncommon even with low serum platelets, a mildly increased international normalized ratio (INR) or when patients are on aspirin.

Additionally, the risk of nondiagnostic findings is independently predicted by cystic features, hypo-enhancement on imaging, a smaller mass diameter and a longer skin-to-tumour distance.

A total of 1,155 biopsies were performed in 965 patients, of whom 24 (2.2 percent) had procedural complications, including five (0.4 percent) with major complications (Clavien 3a). None of the patients had tumour seeding of the biopsy tract.

The following factors did not correlate with the risk of complication (p=0.06–0.53): age, gender, body mass index, Charlson comorbidity index, smoking, mass diameter, nephrometry score, number of cores and prior biopsy.

Complications were not elevated for patients taking aspirin (p=0.16) or those with low platelets (25,000–160,000/μl blood; p=0.07) or a mildly increased INR (1.2–2.0; p=0.50). No increase in complication risk was seen during the initial 50 cases of a radiologist (p=0.35) or when a trainee was present (p=0.12).

Of the biopsies, 14.6 percent presented with nondiagnostic findings, which were independently associated with cystic features (p<0.001), contrast enhancement (p=0.002), mass diameter (p=0.02) and skin-to-mass distance (p=0.049), but not with radiologist experience (p=0.23). Previous nondiagnostic biopsy did not correlate with an elevated nondiagnostic rate on subsequent attempts (19.2 percent vs 14.2 percent; p=0.23).

In this study, the authors reviewed core renal mass biopsies from 2000 to 2017 and used the Clavien-Dindo system to grade complications at 30 days. They also performed univariate and multivariate analyses to examine associations between clinical characteristics and the risk of complications or nondiagnostic findings.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, 2 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 3 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
14 Sep 2019
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.